rejection

(redirected from Acute Rejection)
Also found in: Dictionary, Medical, Legal, Financial, Acronyms, Encyclopedia, Wikipedia.
  • noun

Synonyms for rejection

Synonyms for rejection

a negative response

Synonyms

a refusal to grant the truth of a statement or charge

a turning down of a request

Antonyms for rejection

References in periodicals archive ?
At the conclusion of the 42-day postsurgery study period, the incidences of acute rejection and of toxicity requiring tacrolimus dosage adjustment were the outcomes measured.
28,33,42) Cytomegalovirus enteritis may clinically mimic acute rejection with symptoms of diarrhea and epigastric pain.
20) pointed out higher acute rejection incidence in female recipients in the first 6 months and declared early mortality (< 6 months) caused by infection.
Acute rejection following lung transplantation: Limitations in accuracy of thin-section CT for diagnosis.
In pediatric patients, the safety and efficacy of Rapamune have not been established in kidney transplant patients less than 13 years old, or in patients less than 18 years old who are considered at high risk of acute rejection.
Acute rejection in renal transplantation recipients treated with tacrolimus prolonged release- and immediate release-based therapy - the OSAKA study (oral presentation by Professor Dr Bernhard Banas, University Medical Center Regensburg, Germany)
2]-monitored patients, with no significant effect on the rate of acute rejection for a majority of these studies.
African -American recipients also are more likely than Caucasians to experience acute rejection.
ATG-Fresenius S is an immunosuppressive polyclonal antibody product for the prevention and treatment of acute rejection following organ transplantation.
Despite recent advances in immunosuppressive agents, from 20% to 60% of the 12,000 US patients who receive kidney transplants each year experience acute rejection during the first year following transplantation.
CTI says the primary endpoint of the trial is defined as non-inferiority in biopsy proven acute rejection (BPAR) episodes in patients receiving ISA247 for six months compared to the tacrolimus control.
Thymoglobulin(R) (Anti-thymocyte globulin (Rabbit)) was introduced to the US market in 1999 for the treatment of renal transplant acute rejection, and according to IMS data has since captured the top spot in US immunosuppressive antibody therapies.
The 6-month results revealed that Prograf(R) in combination with the higher dose of sirolimus (2mg) was associated with a significantly lower incidence of biopsy-proven acute rejection (15.
The company says myfortic successfully completed the European Mutual Recognition Procedure (MRP) and was approved for the prevention of acute rejection of kidney allografts in adult patients on February 7, 2004.
Thymoglobulin, a drug that could prevent organ loss for kidney transplant recipients experiencing acute rejection, was already the market leader in Europe and is now the worldwide leader in immunosuppressive antibodies.
Full browser ?